Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide

By Frangione-Beebe M.   Albrecht B.   Dakappagari N.   Rose R.T.   Brooks C.L.   Schwendeman S.P.   Lairmore M.D.   Kaumaya P.T.P.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1068-1081

Elsevier

Access to resources Recommend Favorite

Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3 N306 glycan

By Bolmstedt A.   Hinkula J.   Rowcliffe E.   Biller M.   Wahren B.   Olofsson S.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 397-405

Elsevier

Access to resources Recommend Favorite

Erratum to ''An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA ( R)) in adults: safety, tolerability, and immunogenicity'' - [Vaccine 19 (2001) 3968-3971]

By Linglof T.   Hattum J.v.   Kaplan K.M.   Corrigan J.   Duval I.   Jensen E.   Kuter B.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 281-281

Elsevier

Access to resources Recommend Favorite

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

By Gorse G.J.   Patel G.B.   Mandava M.D.   Belshe R.B.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 835-849

Elsevier

Access to resources Recommend Favorite

The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys

By Skiadopoulos M.H.   Tatem J.M.   Surman S.R.   Mitcho Y.   Wu S.-L.   Elkins W.R.   Murphy B.R.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1846-1852

Elsevier

Access to resources Recommend Favorite